FDA Bars Avastin's Use As Breast Cancer Treatment
The U.S. Food and Drug Administration on Friday withdrew its approval of blockbuster Genentech Inc. drug Avastin for the treatment of breast cancer, citing its potentially fatal side effects and a...To view the full article, register now.
Already a subscriber? Click here to view full article